Treating vulvovaginal atrophy/genitourinary syndrome of menopause: how important is vaginal lubricant and moisturizer composition?
Лечение вульвовагинальной атрофии/урогенитального менопаузального синдрома: насколько важен состав вагинальных лубрикантов и увлажняющих средств?
2015-12-26
SCID: 54.1/ffwctk5c
Discuss with AI
genitourinary syndrome of menopauseosmolality and pHvaginal drynessvaginal lubricants and moisturizersvulvovaginal atrophy
Figures from the paper
Abstract (AI)
Vaginal dryness is a common condition that is particularly prevalent during and after the menopause, and is one of the symptoms of vulvovaginal atrophy/genitourinary syndrome of menopause. The impact of vaginal dryness on interpersonal relationships, quality of life, daily activities, and sexual function can be significant, but is frequently underestimated. Furthermore, barriers exist to treatment-seeking, and this condition is often underreported and undertreated. Greater education about vaginal dryness and the range of available treatments is essential to encourage more women to seek help for this condition. Personal lubricants and moisturizers are effective at relieving discomfort and pain during sexual intercourse for women with mild to moderate vaginal dryness, particularly those who have a genuine contraindication to estrogen, or who choose not to use estrogen. However, there is a distinction between lubricants and moisturizers, and notable differences between commercially available products. Women should be advised to choose a product that is optimally balanced in terms of both osmolality and pH, and is physiologically most similar to natural vaginal secretions. A series of recommendations for the use of vaginal lubricants and moisturizers, either on their own or in combination with systemic or topical hormone replacement therapy, is presented.
Key Findings
1
Lubricants and moisturizers are distinct product categories, and commercially available products differ meaningfully in composition.
2
Personal lubricants and moisturizers relieve discomfort and dyspareunia in women with mild to moderate vaginal dryness, especially when estrogen is contraindicated or declined.
3
Products should be selected for physiologically appropriate osmolality and pH, approximating natural vaginal secretions.
4
The abstract provides recommendations for using lubricants and moisturizers alone or alongside systemic or topical hormone replacement therapy.
5
Vaginal dryness is common during and after menopause, substantially affecting relationships, quality of life, daily activities, and sexual function while remaining underreported and undertreated.
Research Object
Vaginal lubricants and moisturizers used to treat vaginal dryness associated with vulvovaginal atrophy/genitourinary syndrome of menopause
Research Subject
The importance of lubricant and moisturizer composition, particularly osmolality and pH, for relieving vaginal discomfort and dyspareunia and guiding product selection and use alone or with hormone replacement therapy
Publication Details
Publication Date
2015-12-26
Journal
Publisher
ISSN
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest